ChemoCentryx
CCXI
#3557
Rank
ยฃ2.80 B
Marketcap
ยฃ39.02
Share price
0.00%
Change (1 day)
27.95%
Change (1 year)

Revenue for ChemoCentryx (CCXI)

Revenue in 2022 (TTM): ยฃ28.65 Million

According to ChemoCentryx's latest financial reports the company's current revenue (TTM ) is ยฃ27.91 Million. In 2021 the company made a revenue of ยฃ23.63 Million a decrease over the revenue in the year 2020 that were of ยฃ47.24 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ChemoCentryx from 2011 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) ยฃ28.65 M21.24%
2021 ยฃ23.63 M-49.97%
2020 ยฃ47.24 M72.3%
2019 ยฃ27.41 M-18.83%
2018 ยฃ33.77 M-44.66%
2017 ยฃ61.04 M558.67%
2016 ยฃ9.26 M
2015 N/A
2014 N/A-100%
2013 ยฃ3.67 M9.58%
2012 ยฃ3.35 M-83.55%
2011 ยฃ20.37 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Biogen
BIIB
ยฃ7.55 B 26,958.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ44.76 B 160,233.33%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ31.78 B 113,751.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
ยฃ36.04 B 129,023.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.15 B 247,612.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ26.99 B 96,596.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.12 B 168,679.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ12.59 B 44,996.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
ยฃ48.20 B 172,574.73%๐Ÿ‡บ๐Ÿ‡ธ USA